ROS1 and lung cancer: These Hsp90 inhibitors suppressed ROS1 phosphorylation in wild-type CD74-ROS1, F2004V-, or F2075C-mutated cells (Supplementary Fig. S9C–E) similarly to what has been observed in ROS1-rearranged lung cancer cells43.